PUBLIC CONTRACT · 2025
ECULIZUMAB 300 MG SOL INJ FR 30 ML IV para as necessidades imediatas - AD 92142725
- Contract value
- €6,163.50
- Signed on
- 27 August 2025
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11673691PUBLISHED SUBJECT
ECULIZUMAB 300 MG SOL INJ FR 30 ML IV para as necessidades imediatas - AD 92142725
Parties involved
- Place of performance
- Portugal, Setúbal, Almada
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ALEXION PHARMA SPAIN S L - SUCURSAL PORTUGAL · Tax ID 980553768
Values and timeline
- Contract price
- €6,163.50
- Procedure base price
- €6,163.50
- Total effective price
- Not reported on Portal BASE
- Publication date
- 1 September 2025
- Award date
- 25 August 2025
- Signing date
- 27 August 2025
- Performance period
- 2 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7812012
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.